We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
-1.69%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$81.2M
Cap. Flow
-$35.7M
Cap. Flow %
-3.03%
Top 10 Hldgs %
45.55%
Holding
361
New
6
Increased
18
Reduced
44
Closed
12

Top Buys

Rank Stock Value
1
TRV icon
Travelers Companies
TRV
+$2.13M
2
MDT icon
Medtronic
MDT
+$538K
3
LIN icon
Linde
LIN
+$527K
4
NVDA icon
NVIDIA
NVDA
+$344K
5
NKE icon
Nike
NKE
+$335K

Top Sells

Rank Stock Value
1
TFX icon
Teleflex
TFX
+$10M
2
ADBE icon
Adobe
ADBE
+$8.92M
3
EMR icon
Emerson Electric
EMR
+$4.71M
4
STE icon
Steris
STE
+$2.25M
5
JPM icon
JPMorgan Chase
JPM
+$1.12M

Sector Composition

Rank Sector Weight
1 Industrials 25.07%
2 Financials 20.31%
3 Technology 15.43%
4 Consumer Discretionary 15.04%
5 Healthcare 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$324B
$14.6M 1.24%
162,550
– –
NSC icon
27
Norfolk Southern
NSC
$78.8B
$13.5M 1.14%
56,880
– –
DIS icon
28
Walt Disney
DIS
$165B
$12.8M 1.08%
129,318
+165
+0.1% +$17.7K
XOM icon
29
ExxonMobil
XOM
$651B
$11.6M 0.99%
97,601
– –
NKE icon
30
Nike
NKE
$61.9B
$11.6M 0.99%
182,720
+4,545
+3% +$335K
MCD icon
31
McDonald's
MCD
$188B
$8.53M 0.73%
27,320
-580
-2% -$173K
EMR icon
32
Emerson Electric
EMR
$82.9B
$7.51M 0.64%
68,535
-39,050
-36% -$4.71M
DMRC icon
33
Digimarc Corp
DMRC
$133M
$7.37M 0.63%
575,242
-7,535
-1% -$215K
ABBV icon
34
AbbVie
ABBV
$458B
$6.51M 0.55%
31,070
– –
CVX icon
35
Chevron
CVX
$388B
$6.3M 0.54%
37,682
– –
NVDA icon
36
NVIDIA
NVDA
$5.01T
$6.07M 0.52%
56,049
+2,716
+5% +$344K
CAC icon
37
Camden National
CAC
$924M
$6.03M 0.51%
148,997
-800
-0.5% -$34.5K
MTB icon
38
M&T Bank
MTB
$36.2B
$5.35M 0.45%
29,950
– –
GOOG icon
39
Alphabet (Google) Class C
GOOG
$3.9T
$5.28M 0.45%
33,795
-574
-2% -$105K
NEE icon
40
NextEra Energy
NEE
$187B
$4.85M 0.41%
68,424
-29
-0% -$2.05K
SHEL icon
41
Shell
SHEL
$245B
$4.85M 0.41%
66,176
– –
AMGN icon
42
Amgen
AMGN
$203B
$4.61M 0.39%
14,800
– –
NUE icon
43
Nucor
NUE
$56.4B
$4.52M 0.38%
37,550
– –
STE icon
44
Steris
STE
$20.9B
$3.51M 0.3%
15,466
-10,207
-40% -$2.25M
PG icon
45
Procter & Gamble
PG
$343B
$3.35M 0.28%
19,670
– –
ABT icon
46
Abbott
ABT
$180B
$3.14M 0.27%
23,639
-6,300
-21% -$802K
MRSH
47
Marsh
MRSH
$86.3B
$3.12M 0.27%
12,795
– –
TRV icon
48
Travelers Companies
TRV
$80.8B
$2.26M 0.19%
+8,536
New +$2.13M
GE icon
49
GE Aerospace
GE
$367B
$2.07M 0.18%
10,324
-1
-0% -$197
JNJ icon
50
Johnson & Johnson
JNJ
$635B
$1.72M 0.15%
10,396
– –
1
2
3 4 5

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q1 2025 Portfolio in Review

As of Q1 2025, Kimelman & Baird held 361 positions worth $1.18B, down 6.5% from $1.26B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Kimelman & Baird withdrew a net $35.7M in Q1 2025, closing 12 positions and reducing 44 holdings. Its most notable exit was Cigna, an estimated $443K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Kimelman & Baird opened a new position in Travelers Companies worth $2.26M.

  • Kimelman & Baird's largest Q1 2025 buy was Travelers Companies: 8,536 shares worth $2.26M.
  • Kimelman & Baird added most to Medtronic in Q1 2025, an estimated $538K increase.
  • Kimelman & Baird's biggest Q1 2025 reduction was Teleflex, cutting an estimated $10M.
  • Kimelman & Baird fully exited Cigna in Q1 2025, selling an estimated $443K.
  • Kimelman & Baird's ten largest holdings make up 46% of its $1.18B portfolio in Q1 2025.
  • Kimelman & Baird opened 6 new positions and closed 12 in Q1 2025.
  • Kimelman & Baird's portfolio value fell 6.5% quarter-over-quarter to $1.18B.

Based on Kimelman & Baird's 13F filing for Q1 2025, filed 13 May 2025.